StockData
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI) stock

PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$1.01−0.02 (-1.94%)

Close on Nov 17, 2026Market cap $176.01MP/E –Yield –

Palisade Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Palisade Bio's price to book ratio was 1.7× on Nov 11, 2026, against 6.0× a year earlier. Over the last 5 years it ranged from 0.2× to 6.7×, with a median of 0.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×−5.0
2025Dec 31, 20256.7×+6.4
2024Dec 31, 20240.3×−0.1
2023Dec 29, 20230.4×−0.3
2022Dec 30, 20220.6×−3.6
2021Dec 31, 20214.3×+1.5
2020Jan 31, 20202.8×+0.4
2019Dec 31, 20192.4×−4.0
2018Dec 31, 20186.4×−7.1
2017Dec 29, 201713.5×−200.7
2016Oct 31, 2016214.2×+150.4
2015Dec 31, 201563.8×−4.3
2014Dec 31, 201468.1×−93.8
2013Dec 31, 2013161.9×+112.9
2012Dec 31, 201248.9×−23.8
2011Dec 30, 201172.7×–

More Palisade Bio figures

See a number that looks wrong?